Sexual Dysfunction Related to Drugs: A Critical Review. Part IV: Cardiovascular Drugs
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Sexual Dysfunction Related to Drugs: A Critical Review. Part IV: Cardiovascular Drugs ; volume:48 ; number:01 ; year:2015 ; pages:1-6
Pharmacopsychiatry ; 48, Heft 01 (2015), 1-6
- Contributor
-
La Torre, A.
Giupponi, G.
Duffy, D.
Conca, A.
Catanzariti, D.
- DOI
-
10.1055/s-0034-1395515
- URN
-
urn:nbn:de:101:1-2019011107591736360905
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- La Torre, A.
- Giupponi, G.
- Duffy, D.
- Conca, A.
- Catanzariti, D.
Other Objects (12)
Drug treatment of sexual dysfunction
Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
Sexual Dysfunction Related to Psychotropic Drugs: A Critical Review – Part I: Antidepressants
Sexual Dysfunction Related to Psychotropic Drugs: A Critical Review Part II: Antipsychotics
Cardiovascular drugs and therapy : CDT
Repurposing of approved cardiovascular drugs
American journal of cardiovascular drugs : drugs, devices and other interventions
Drug–Drug, Drug–Disease and Disease–Disease Interactions in COVID-19 with Cardiovascular Diseases (CVDs)
Pharmaceuticals, Vol. 1.. Introduction; Cardiovascular drugs
Striatal dopamine transporter imaging in Parkinson’s disease drug-naïve patients: focus on sexual dysfunction
The Grand Challenges in Cardiovascular Drug Delivery
Drugs compromising male sexual health : [with CD-ROM]
Drug treatment of sexual dysfunction
Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
Sexual Dysfunction Related to Psychotropic Drugs: A Critical Review – Part I: Antidepressants
Sexual Dysfunction Related to Psychotropic Drugs: A Critical Review Part II: Antipsychotics
Cardiovascular drugs and therapy : CDT
Repurposing of approved cardiovascular drugs
American journal of cardiovascular drugs : drugs, devices and other interventions
Drug–Drug, Drug–Disease and Disease–Disease Interactions in COVID-19 with Cardiovascular Diseases (CVDs)
Pharmaceuticals, Vol. 1.. Introduction; Cardiovascular drugs
Striatal dopamine transporter imaging in Parkinson’s disease drug-naïve patients: focus on sexual dysfunction
The Grand Challenges in Cardiovascular Drug Delivery
Drugs compromising male sexual health : [with CD-ROM]
Drug treatment of sexual dysfunction
Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
Sexual Dysfunction Related to Psychotropic Drugs: A Critical Review – Part I: Antidepressants
Sexual Dysfunction Related to Psychotropic Drugs: A Critical Review Part II: Antipsychotics
Cardiovascular drugs and therapy : CDT
Repurposing of approved cardiovascular drugs
American journal of cardiovascular drugs : drugs, devices and other interventions
Drug–Drug, Drug–Disease and Disease–Disease Interactions in COVID-19 with Cardiovascular Diseases (CVDs)
Pharmaceuticals, Vol. 1.. Introduction; Cardiovascular drugs
Striatal dopamine transporter imaging in Parkinson’s disease drug-naïve patients: focus on sexual dysfunction
The Grand Challenges in Cardiovascular Drug Delivery